Most read article(s)

Open Access
Nelfinavir and Its Active Metabolite M8 Are Partial Agonists and Competitive Antagonists of the Human Pregnane X Receptor
Oliver Burk, Thales Kronenberger, Oliver Keminer, Serene M. L. Lee, Tobias S. Schiergens, Matthias Schwab and Björn Windshügel

Molecular Pharmacology March 2021, 99 (3) 184-196; DOI: https://doi.org/10.1124/molpharm.120.000116
You have access
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram and Paul A. Insel

Molecular Pharmacology April 2018, 93 (4) 251-258; DOI: https://doi.org/10.1124/mol.117.111062
You have access
Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action
A. Ashna, D.F. van Helden, C. dos Remedios, P. Molenaar and D.R. Laver

Molecular Pharmacology April 2020, 97 (4) 250-258; DOI: https://doi.org/10.1124/mol.119.117721
You have access
Epigenetic Mechanisms Underlying Organic Solute Transporter β Repression in Colorectal Cancer
Ying Zhou, Chaonan Ye, Yan Lou, Junqing Liu, Sheng Ye, Lu Chen, Jinxiu Lei, Suhang Guo, Su Zeng and Lushan Yu

Molecular Pharmacology April 2020, 97 (4) 259-266; DOI: https://doi.org/10.1124/mol.119.118216
Open Access
Wnt Signaling and Drug Resistance in Cancer
Zheng Zhong and David M. Virshup

Molecular Pharmacology February 2020, 97 (2) 72-89; DOI: https://doi.org/10.1124/mol.119.117978
You have access
Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill
Xiaolei Xie, Guangan He and Zahid H. Siddik

Molecular Pharmacology April 2020, 97 (4) 237-249; DOI: https://doi.org/10.1124/mol.119.117564
You have access
Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk
Nadine Kabbani and James L. Olds

Molecular Pharmacology May 2020, 97 (5) 351-353; DOI: https://doi.org/10.1124/molpharm.120.000014
You have access
Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen

Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151
You have access
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
Nadine Wenningmann, Merle Knapp, Anusha Ande, Tanaya R. Vaidya and Sihem Ait-Oudhia

Molecular Pharmacology August 2019, 96 (2) 219-232; DOI: https://doi.org/10.1124/mol.119.115725
Open Access
Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus
Elham Gholizadeh, Reza Karbalaei, Ali Khaleghian, Mona Salimi, Kambiz Gilany, Rabah Soliymani, Ziaurrehman Tanoli, Hassan Rezadoost, Marc Baumann, Mohieddin Jafari and Jing Tang

Molecular Pharmacology May 2021, 99 (5) 308-318; DOI: https://doi.org/10.1124/molpharm.120.000210

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals